B
BEAUTY HEALTH CO
NASDAQ: SKIN (The Beauty Health Company)
Last update: yesterday, 1:19PM1.27
0.21 (19.81%)
| Previous Close | 1.06 |
| Open | 1.13 |
| Volume | 2,002,647 |
| Avg. Volume (3M) | 603,498 |
| Market Cap | 161,928,880 |
| Price / Earnings (Forward) | 106.38 |
| Price / Sales | 0.520 |
| Price / Book | 2.21 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2026 |
| Profit Margin | -11.94% |
| Operating Margin (TTM) | -17.28% |
| Diluted EPS (TTM) | -0.340 |
| Quarterly Revenue Growth (YOY) | -14.50% |
| Quarterly Earnings Growth (YOY) | -94.00% |
| Total Debt/Equity (MRQ) | 1,232.44% |
| Current Ratio (MRQ) | 7.47 |
| Operating Cash Flow (TTM) | 35.98 M |
| Levered Free Cash Flow (TTM) | 46.98 M |
| Return on Assets (TTM) | -5.17% |
| Return on Equity (TTM) | -70.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Household & Personal Products (US) | Mixed | Bearish |
| Household & Personal Products (Global) | Mixed | Bearish | |
| Stock | The Beauty Health Company | Bearish | Bullish |
AIStockmoo Score
1.1
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
|
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products. |
|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Investment Style | Small Core |
| % Held by Insiders | 10.07% |
| % Held by Institutions | 83.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Silver Point Capital L.P. | 31 Dec 2025 | 1,592,030 |
| Glendon Capital Management Lp | 31 Dec 2025 | 636,954 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 1.65 (TD Cowen, 29.92%) | Hold |
| Median | 1.63 (28.35%) | |
| Low | 1.60 (Jefferies, 25.98%) | Hold |
| Average | 1.63 (28.35%) | |
| Total | 2 Hold | |
| Avg. Price @ Call | 1.54 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 21 Jan 2026 | 1.65 (29.92%) | Hold | 1.54 |
| Jefferies | 14 Jan 2026 | 1.60 (25.98%) | Hold | 1.54 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |